Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling of eyelid, Vaccination site pain, Visual impairment
Clinical narrative: substantial exposure to Covid-19; field of vision was not normal; eyes were swelling and lowered; eye leads were swollen; arm a little sore; fatigue; potential allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm a little sore), EXPOSURE TO SARS-COV-2 (substantial exposure to Covid-19), ALLERGY TO VACCINE (potential allergic reaction), FATIGUE (fatigue) and VISUAL IMPAIRMENT (field of vision was not normal) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0381C20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Seasonal allergy: ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE] since an unknown date.  Concurrent medical conditions included Dust allergy, Allergy to molds, Allergy to animals (Cats), Pollen allergy, Grass allergy (Allergic to trees), Allergy to chemicals (Patient is allergic to Codeine, Ziprol and Lagil) and Osteopenia (Patient has Osteopenia and receive a shot for this every 6 month). Concomitant products included GLUCOSAMINE for Joint pain, LEVOTHYROXINE, TRANEXAMIC ACID (NEXIM), MULTIVITAMIN [ASCORBIC ACID;BIOTIN;CALCIUM PANTOTHENATE;CYANOCOBALAMIN;FOLIC ACID;NICOTINIC ACID;PYRIDOXINE HYDROCHLORIDE;RIBOFLAVIN;THIAMINE HYDROCHLORIDE;TOCOPHERYL ACETATE], VITAMIN E NOS and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.   On 22-Jan-2021 at 4:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced ALLERGY TO VACCINE (potential allergic reaction).   On 22-Jan-2021, the patient experienced VACCINATION SITE PAIN (arm a little sore) and FATIGUE (fatigue).   On 23-Jan-2021, the patient experienced VISUAL IMPAIRMENT (field of vision was not normal), EYE SWELLING (eyes were swelling and lowered) and SWELLING OF EYELID (eye leads were swollen). On an unknown date, the patient experienced EXPOSURE TO SARS-COV-2 (substantial exposure to Covid-19). The patient was treated with PREDNISONE for Allergy, at a dose of 15 milligram and CHLORPHENAMINE MALEATE (ANTIHISTAMINICO) on 23-Jan-2021 for Swollen eyes, at an unspecified dose and frequency.   At the time of the report, VACCINATION SITE PAIN (arm a little sore) outcome was unknown, EXPOSURE TO SARS-COV-2 (substantial exposure to Covid-19) had resolved and ALLERGY TO VACCINE (potential allergic reaction), FATIGUE (fatigue), VISUAL IMPAIRMENT (field of vision was not normal), EYE SWELLING (eyes were swelling and lowered) and SWELLING OF EYELID (eye leads were swollen) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test negative: negative (Negative) Patient was tested negative when she was taking care of her grandchild's who tested positive.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Patient treated swelling with Eye compress.